Guidelines for in vivo mouse models of myocardial infarction.
Merry L LindseyKeith R BruntJonathan A KirkPetra KleinbongardJohn W CalvertLisandra E de Castro BrásKristine Y DeLeon-PennellDominic P Del ReNikolaos G FrangogiannisStefan FrantzRichard J GuminaGanesh V HaladeSteven R JonesRebecca Helen RitchieFrancis G SpinaleEdward B ThorpCrystal M RipplingerZamaneh KassiriPublished in: American journal of physiology. Heart and circulatory physiology (2021)
Despite significant improvements in reperfusion strategies, acute coronary syndromes all too often culminate in a myocardial infarction (MI). The consequent MI can, in turn, lead to remodeling of the left ventricle (LV), the development of LV dysfunction, and ultimately progression to heart failure (HF). Accordingly, an improved understanding of the underlying mechanisms of MI remodeling and progression to HF is necessary. One common approach to examine MI pathology is with murine models that recapitulate components of the clinical context of acute coronary syndrome and subsequent MI. We evaluated the different approaches used to produce MI in mouse models and identified opportunities to consolidate methods, recognizing that reperfused and nonreperfused MI yield different responses. The overall goal in compiling this consensus statement is to unify best practices regarding mouse MI models to improve interpretation and allow comparative examination across studies and laboratories. These guidelines will help to establish rigor and reproducibility and provide increased potential for clinical translation.
Keyphrases
- acute coronary syndrome
- heart failure
- mouse model
- left ventricular
- percutaneous coronary intervention
- healthcare
- acute myocardial infarction
- primary care
- oxidative stress
- antiplatelet therapy
- pulmonary hypertension
- coronary artery disease
- sensitive detection
- coronary artery
- pulmonary artery
- fluorescent probe
- living cells
- case control
- cardiac resynchronization therapy